Literature DB >> 26430575

Surgical Management of Sacral Chordomas: Illustrative Cases and Current Management Paradigms.

Arjun V Pendharkar1, Allen L Ho1, Eric S Sussman1, Atman Desai1.   

Abstract

Sacral chordomas represent more than 50% of all sacral tumors. These slow-growing, malignant lesions present insidiously and are often large and intimately involved with sacral neurovascular and pelvic structures. En bloc resection is the only well-established predictor of progression-free survival. Optimal surgical management requires a complex multi-disciplinary approach. Here, we describe two cases of sacral chordoma and review current management paradigms.

Entities:  

Keywords:  sacral chordoma

Year:  2015        PMID: 26430575      PMCID: PMC4571900          DOI: 10.7759/cureus.301

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  23 in total

Review 1.  Chordoma: current concepts, management, and future directions.

Authors:  Brian P Walcott; Brian V Nahed; Ahmed Mohyeldin; Jean-Valery Coumans; Kristopher T Kahle; Manuel J Ferreira
Journal:  Lancet Oncol       Date:  2012-02       Impact factor: 41.316

2.  Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Authors:  Debraj Mukherjee; Kaisorn L Chaichana; Ziya L Gokaslan; Oran Aaronson; Joseph S Cheng; Matthew J McGirt
Journal:  J Neurosurg Spine       Date:  2010-12-24

3.  Operative management of sacral chordoma.

Authors:  Bruno Fuchs; Ian D Dickey; Michael J Yaszemski; Carrie Y Inwards; Franklin H Sim
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

4.  Prognostic Factors in the Operative Management of Sacral Chordomas.

Authors:  Babar Kayani; Mathew David Sewell; Kimberly-Anne Tan; Sammy A Hanna; Richard Williams; Robin Pollock; John Skinner; Timothy W R Briggs
Journal:  World Neurosurg       Date:  2015-06-23       Impact factor: 2.104

5.  Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable.

Authors:  Wouter A Moojen; Carmen L A Vleggeert-Lankamp; Augustinus D G Krol; Sander P D Dijkstra
Journal:  Spine (Phila Pa 1976)       Date:  2011-05-01       Impact factor: 3.468

6.  Lumbosacral chordoma. Prognostic factors and treatment.

Authors:  E Y Cheng; R A Ozerdemoglu; E E Transfeldt; R C Thompson
Journal:  Spine (Phila Pa 1976)       Date:  1999-08-15       Impact factor: 3.468

Review 7.  Current management of sacral chordoma.

Authors:  Daryl R Fourney; Ziya L Gokaslan
Journal:  Neurosurg Focus       Date:  2003-08-15       Impact factor: 4.047

8.  Clinicopathologic study of sacrococcygeal chordoma.

Authors:  T E Kaiser; D J Pritchard; K K Unni
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

9.  Sacrectomy and adjuvant radiotherapy for the treatment of sacral chordomas: a single-center experience over 27 years.

Authors:  Arjun A Dhawale; Joseph P Gjolaj; Laurens Holmes; Laurence R Sands; H Thomas Temple; Frank J Eismont
Journal:  Spine (Phila Pa 1976)       Date:  2014-03-01       Impact factor: 3.468

10.  The surgical management of sacral chordomas.

Authors:  Joseph H Schwab; John H Healey; Peter Rose; Jorge Casas-Ganem; Patrick J Boland
Journal:  Spine (Phila Pa 1976)       Date:  2009-11-15       Impact factor: 3.468

View more
  2 in total

1.  Exophytic Lumbar Vertebral Body Mass in an Adult with Back Pain.

Authors:  J C Benson; M A Vizcaino; D K Kim; C Carr; P Rose; L Eckel; F Diehn
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

Review 2.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.